Journal of Hepatology

Volume Contents
pp. III-XV(1)

Author Index
pp. XVII-XIX(1)

Subject Index
pp. XIX-XXI(1)

Editorial Board
pp. v-v

The Bridge - June 2003
pp. 703-703(1)
Author: Reichen J.

The discovery of the new haemochromatosis gene - Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [Nat Genet 1996;13:399-408]
pp. 704-709(6)
Author: Brissot P.

Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice
pp. 710-716(7)
Authors: Kosters A.; Frijters R.J.J.M.; Schaap F.G.; Vink E.; Plosch T.; Ottenhoff R.; Jirsa M.; De Cuyper I.M.; Kuipers F.; Groen A.K.

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
pp. 717-727(11)
Authors: Zollner G.; Fickert P.; Silbert D.; Fuchsbichler A.; Marschall H.-U.; Zatloukal K.; Denk H.; Trauner M.

Sensitization by interleukin-6 of rat hepatocytes to tumor necrosis factor -induced apoptosis
pp. 728-735(8)
Authors: Boer U.; Fennekohl A.; Puschel G.P.

Primary human hepatocytes - a valuable tool for investigation of apoptosis and hepatitis B virus infection
pp. 736-744(9)
Authors: Schulze-Bergkamen H.; Untergasser A.; Dax A.; Vogel H.; Buchler P.; Klar E.; Lehnert T.; Friess H.; Buchler M.W.; Kirschfink M.; Stremmel W.; Krammer P.H.; Muller M.; Protzer U.

Population screening for hemochromatosis: a study in 5370 Spanish blood donors
pp. 745-750(6)
Authors: Sanchez M.; Villa M.; Ingelmo M.; Sanz C.; Bruguera M.; Ascaso C.; Oliva R.

TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience
pp. 751-754(4)
Authors: Mancuso A.; Fung K.; Mela M.; Tibballs J.; Watkinson A.; Burroughs A.K.; Patch D.

Effect of the V_1a/V₂-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites
pp. 755-761(7)
Authors: Fernandez-Varo G.; Ros J.; Cejudo-Martin P.; Cano C.; Arroyo V.; Rivera F.; Rodes J.; Jimenez W.

Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
pp. 762-769(8)
Authors: Sakaida I.; Tsuchiya M.; Kawaguchi K.; Kimura T.; Terai S.; Okita K.

Cytokeratin 7 staining of hepatocytes predicts progression to more severe fibrosis in alcohol-fed baboons
pp. 770-775(6)
Authors: Ren C.; Paronetto F.; Mak K.M.; Leo M.A.; Lieber C.S.

Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity
pp. 776-783(8)
Authors: Cantoni L.; Valaperta R.; Ponsoda X.; Castell J.V.; Barelli D.; Rizzardini M.; Mangolini A.; Hauri L.; Villa P.

Gene expression profile in the regenerating rat liver after partial hepatectomy
pp. 784-792(9)
Authors: Fukuhara Y.; Hirasawa A.; Li X.-K.; Kawasaki M.; Fujino M.; Funeshima N.; Katsuma S.; Shiojima S.; Yamada M.; Okuyama T.; Suzuki S.; Tsujimoto G.

Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model
pp. 793-802(10)
Authors: Dupuy E.; Hainaud P.; Villemain A.; Bodevin-Phedre E.; Brouland J.P.; Briand P.; Tobelem G.

Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor
pp. 803-810(8)
Authors: Wiedmann M.; Tamaki S.; Silberman R.; de la Monte S.M.; Cousens L.; Wands J.R.

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
pp. 811-817(7)
Authors: Buti M.; Mas A.; Prieto M.; Casafont F.; Gonzalez A.; Miras M.; Herrero J.-I.; Jardi R.; Cruz de Castro E.; Garcia-Rey C.

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
pp. 818-826(9)
Authors: Schiff E.R.; Dienstag J.L.; Karayalcin S.; Grimm I.S.; Perrillo R.P.; Husa P.; de Man R.A.; Goodman Z.; Condreay L.D.; Crowther L.M.; Woessner M.A.; McPhillips P.J.; Brown N.A.; the International Lamivudine Investigator Group

Localization of swine hepatitis E virus in liver and extrahepatic tissues from naturally infected pigs by in situ hybridization
pp. 827-832(6)
Authors: Choi C.; Chae C.

Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients
pp. 833-842(10)
Authors: Belec L.; Legoff J.; Si-Mohamed A.; Bloch F.; Mbopi Keou F.-X.; Becquart P.; Matta M.; Prazuck T.; Petite J.-P.; Gutmann L.; Payan C.

Biliary cholesterol secretion: more lessons from plants?
pp. 843-846(4)
Author: Stieger B.

Transcriptional profiling of liver regeneration: new approaches to an old trick!
pp. 847-849(3)
Authors: Mitchell C.; Gilgenkrantz H.

Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?
pp. 850-852(3)
Author: Zoulim F.

Treatment options for chronic hepatitis B not responding to interferon
pp. 853-855(3)
Author: Hadziyannis S.J.

Osteoporosis in liver diseases and after liver transplantation
pp. 856-865(10)
Author: Hay J.E.

Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis
pp. 866-869(4)
Authors: Leroy-Matheron C.; Duvoux C.; Van Nhieu J.T.; Leroy K.; Cherqui D.; Gouault-Heilmann M.

Hepatic cyst rupture after a coughing fit
pp. 870-870(1)
Authors: Shutsha E.; Brenard R.

Severe migraine headaches are caused by ribavirin but not by interferon -2b in combination therapy for chronic hepatitis C
pp. 871-872(2)
Authors: Brau N.; Bini E.J.; Stancic S.; Finch D.A.; Aytaman A.

Beyond the journal comment
pp. 873-875(3)
Authors: Schoemaker M.H.; Moshage H.

Corrigendum to ''Management of chronic hepatitis B'' [J Hepatol 38 (2003) S90-S103)]
pp. 876-876(1)
Authors: Conjeevaram H.S.; Lok A.S.-F.